{"schema_version":"secwatch.filing_event.v1","accession":"0000200406-24-000088","form_type":"8-K","ticker":"JNJ","cik":"0000200406","company_name":"JOHNSON & JOHNSON","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.554037+00:00","generated_at":"2026-05-30T14:55:34.451631+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Johnson & Johnson Q3 sales up 5.2% to $22.5B; GAAP EPS down 34% to $1.11 on higher R&D and other charges","bullets":["Worldwide sales $22.47B (+5.2% reported, +6.3% operational); MedTech up 5.8%, Innovative Medicine up 4.9%.","GAAP net earnings from continuing ops $2.69B ($1.11 diluted EPS), down 37.5% YoY; adjusted net earnings $5.88B ($2.42 adjusted EPS), down 13.3%.","R&D expense jumped 43.7% to $4.95B (22.0% of sales); other expense net $1.80B vs $0.50B in prior year.","GAAP effective tax rate 19.3% vs 17.4%; adjusted tax rate 19.3% vs 15.6%.","Discontinued ops had no contribution vs $21.7B in prior year (related to Kenvue separation)."],"urls":{"canonical":"https://secwatch.observer/filing/0000200406-24-000088","json":"https://secwatch.observer/filing/0000200406-24-000088.json","markdown":"https://secwatch.observer/filing/0000200406-24-000088.md","text":"https://secwatch.observer/filing/0000200406-24-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/200406/000020040624000088/0000200406-24-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/200406/000020040624000088/jnj-20241015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:55:34.451631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}